It remains unclear, however, how ROCK mediates the inhibitory effect of TFAP2C on Hippo signaling activity and whether TFAP2C/ROCK/Hippo signaling promotes chemotherapeutic resistance in CRC. Here, TFAP2C is linked to colorectal carcinoma.